Moon Rock Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.25 M
- Paid Up Capital ₹ 0.25 M
- Company Age 5 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
About Moon Rock Pharmaceuticals
Moon Rock Pharmaceuticals Private Limited (MRPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 February 2020 (Five years 3 days old ). Its registered office is in Jind, Haryana, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.25 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Baban Kumar, Amit Kumar, Raj Kumar, and One other member serve as directors at the Company.
Company Details
-
Location
Jind, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24304HR2020PTC085285
-
Company No.
085285
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Feb 2020
-
Date of AGM
25 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Moon Rock Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Kumar
|
Director | 05-Apr-2022 | Current |
|
Baban Kumar
|
Director | 05-Apr-2022 | Current |
|
Raj Kumar
|
Director | 10-Feb-2020 | Current |
|
Saurav Soni
|
Director | 10-Feb-2020 | Current |
Financial Performance of Moon Rock Pharmaceuticals.
Moon Rock Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Moon Rock Pharmaceuticals?
Unlock access to Moon Rock Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
R K Mishra Consultancy Private LimitedAmit Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Moon Rock Pharmaceuticals?
Unlock and access historical data on people associated with Moon Rock Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Moon Rock Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moon Rock Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.